Certified by Founder
Lodge
Curi Bio
start up
United States
- Seattle, Washington
- 04/12/2025
- Series B
- $10,000,000
"Human Data for Next Generation Medicines"
Curi Bio unlocks novel workflows and critical human data to inform R&D decision-making. Through an integrated platform featuring advanced 3D tissue models of disease, biosystems enabling clinically relevant functional analyses, and AI/ML-enabled insights, Curi Bio merges functional and analytical assessments for drug safety, efficacy, and potency
- Industry Biotechnology Research
- Website https://www.curibio.com/
- LinkedIn https://www.linkedin.com/company/curibio/
Autolane | $7,400,000 | (Dec 4, 2025)
Gradium | $70,000,000 | (Dec 4, 2025)
Ridley | $6,400,000 | (Dec 4, 2025)
Heven AeroTech | $100,000,000 | (Dec 4, 2025)
PineAI | $25,000,000 | (Dec 4, 2025)
TRIANA Biomedicines | $120,000,000 | (Dec 4, 2025)
Reema Health | $19,000,000 | (Dec 3, 2025)
HotHouse Therapeutics | $3,835,279 | (Dec 3, 2025)
Quickture | $1,900,000 | (Dec 3, 2025)
Ripple Foods | $17,000,000 | (Dec 3, 2025)